GetTopicDetailResponse(id=cbee3652020, topicName=卡波氏肉瘤, introduction=卡波氏肉瘤, content=null, image=null, comments=1, allHits=1232, url=https://h5.medsci.cn/topic?id=36520, type=1, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=29856, tagList=[TagDto(tagId=29856, tagName=卡波氏肉瘤)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=601596, encodeId=c37860159644, content=<a href='/topic/show?id=cbee3652020' target=_blank style='color:#2F92EE;'>#卡波氏肉瘤#</a>Pomalyst作為一種口服藥物，成為20多年來(lái)卡波西肉瘤患者的第一個(gè)治療選擇。, objectTitle=泊馬度胺獲FDA批準(zhǔn)，成為20多年來(lái)艾滋病相關(guān)卡波西肉瘤的首個(gè)治療藥物, objectType=article, longId=194313, objectId=523f194313d8, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/333.jpg, objectUrl=/article/show_article.do?id=523f194313d8, replyNumber=0, likeNumber=157, createdTime=2020-06-06, rootId=0, userName=lovetcm, userId=7a3710, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=523f194313d8, moduleTitle=泊馬度胺獲FDA批準(zhǔn)，成為20多年來(lái)艾滋病相關(guān)卡波西肉瘤的首個(gè)治療藥物, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=523f194313d8)], followStatus=false, userIsMember=false, type=1, lengthMark=0)]
梅斯話題小助手
2020-05-29
